Third Point, an alternative investment firm, completed the acquisition of AS Birch Grove, a diversified alternative credit fund manager, from American Securities, a private equity firm, according to press releases. Financial terms were undisclosed.
AS Birch Grove was advised by GreensLedge and Schulte Roth & Zabel. Third Point was advised by Jefferies & Company and Willkie Farr & Gallagher (led by
Russell Leaf and
Thomas Sharkey). American Securities was advised by Weil Gotshal and Manges (led by
Jonathon Soler and
Brian Parness),
according to press releases and MergerLinks data.
QXO announced it is extending its all-cash tender offer to acquire all outstanding shares of Beacon Roofing Supply for $124.25 per share, according to press releases.
Francisco Partners, a private equity firm, agreed to acquire Quorum Software, a software company, from Thoma Bravo, a private equity firm, according to press releases. Financial terms were not disclosed.
Quorum Software is advised by Citigroup. Francisco Partners is advised by Jefferies & Company, Lincoln International and Sloane & Company (led by
TJ White). Thoma Bravo is advised by Citigroup and FGS Global (led by
Akash Lodh and
Abigail Farr).
Stone Point Capital, an investment firm, completed the investment in Keller Williams, a real estate franchise, according to press releases. Financial terms were not disclosed.
Keller Williams was advised by Citizens M&A and Skadden Arps Slate Meagher & Flom. Stone Point was advised by Kirkland & Ellis (led by
David Feirstein,
Ravi Agarwal and
Patrick Salvo) and Paul Weiss Rifkind Wharton & Garrison, according to press releases and MergerLinks data.
Creative Science, a veterinary medical solutions company, completed the acquisition of Infiniti Medical and Orthomed UK, two globally recognized brands specializing in veterinary interventional radiology, cardiology, soft tissue surgery, and orthopedics, according to press releases. Financial terms were not disclosed.
Infiniti Medical was advised by Hyde Park Capital (led by
Craig Lawson), Skadden Arps Slate Meagher & Flom (led by
Richard West) and Wilson Sonsini Goodrich & Rosati (led by
Jackie Tokuda), according to press releases and MergerLinks data.
Idaho Trust, a provider of trust and wealth management services in Idaho, completed the acquisition of the trust and wealth management division of Bank of Idaho, a provider of a variety of banking and other financial services, according to press releases. Financial terms were not disclosed.
Idaho Trust was advised by Hawley Troxell. Bank of Idaho was advised by MJC Partners and Otteson Shapiro, according to press releases and MergerLinks data.
Pritzker Private Capital, a private equity firm, agreed to acquire Buckman, a family-owned innovator in specialty solutions for water treatment and industrial processes, according to press releases. Financial terms were not disclosed.
Buckman was advised by Evercore and H/Advisors Abernathy (led by
Dan Scorpio). Pritzker Private Capital was advised by JP Morgan, according to press releases.
General Atomics, a defense and diversified technologies company, agreed to acquire North Point Defense, a provider of Signals Intelligence exploitation software and sensor integration, according to press releases. Financial terms were not disclosed.
North Point Defense is advised by Robert W Baird and Miles & Stockbridge, according to press releases and MergerLinks data.
ASGN, a provider of IT services and professional solutions across the commercial and government sectors, completed the acquisition of TopBloc, a high-growth, tech-enabled Workday consultancy, from BV Investment, a private equity firm, for $340m, according to press releases.
ASGN was advised by Sullivan & Cromwell (led by
Patrick S. Brown). BV Investment was advised by Chris Tofalli Public Relations (led by
Chris Tofalli),
according to press releases and MergerLinks data.
FairJourney Biologics, a provider of antibody discovery and development services, completed the acquisition of the South San Francisco facility from Charles River Laboratories International, a pharmaceutical company, according to press releases. Financial terms were not disclosed.
FairJourney Biologics was advised by Zyme Communications (led by
Jake Brown),
according to press releases.
Truelink Capital, a private equity firm, completed the acquisition of R/GA, the creative innovation company, from Interpublic Group, a provider of marketing solutions, according to press releases. Financial terms were not disclosed.
Interpublic Group was advised by Morgan Stanley, according to press releases and MergerLinks data.
Honeywell, an American multinational conglomerate producing commercial and consumer products, agreed to acquire Sundyne, a designer and manufacturer of mission critical flow control equipment, from Warburg Pincus, a private equity firm, for $2.16bn, according to press releases.
Borouge Group International, a new joint venture formed by OMV and ADNOC, agreed to acquire NOVA Chemicals, a Canadian petrochemical company, for $9.4bn, according to press releases.
Cantata Health Solutions, a provider of healthcare technology solutions for behavioral health and human services providers, completed the acquisition of IMA Systems, a New York-based software company, according to press releases. Financial terms were not disclosed.
Sycamore nears acquisition of Walgreens Boots Alliance. (
Bloomberg)
Sycamore Partners is close to acquiring Walgreens Boots Alliance in a deal that would take the drugstore operator private.
The private equity firm and Walgreens are finalizing the transaction. Sycamore is set to acquire Walgreens for $11.30 to $11.40 per share in cash, valuing the deal at $10bn.
Carlyle targets up to $5bn in exits as IPO market rebounds. (
PE Insights)
Carlyle Group is accelerating its exit strategy, aiming to generate up to $5bn from asset sales this year through IPOs and divestments, aligning with its 2024 performance.
The private equity firm expects dealmaking to gain momentum despite a slow start, supported by improving economic conditions and market stability. Carlyle’s private equity Co-Heads, Brian Bernasek and Steve Wise, see positive shifts in the US dealmaking environment, citing clearer interest rate outlooks, stabilizing inflation, and record-high stock market valuations.
